Politan Capital Management Issues Open Letter to Masimo Corporation Shareholders
New York, NY – Politan Capital Management, a major shareholder of Masimo Corporation, has released a letter to shareholders urging support for its nominees at the upcoming Annual Meeting of Stockholders.
Dear Fellow Masimo Shareholders,
Politan Capital Management, together with its affiliates, has recently announced its 8.9% stake in Masimo Corporation and its intention to nominate independent directors at the Company’s 2024 Annual Meeting of Stockholders.
As long-term shareholders of Masimo, we believe that the Company has significant potential for growth and value creation. However, we are concerned about certain strategic decisions and corporate governance practices that have not fully aligned with the best interests of shareholders.
Our nominees bring a wealth of experience in healthcare and finance, and we are confident that they can provide the leadership needed to guide Masimo towards a brighter future. We urge our fellow shareholders to support our slate of directors at the upcoming Annual Meeting.
Thank you for your attention and support.
How This Will Affect You
If you are a shareholder of Masimo Corporation, the outcome of the upcoming Annual Meeting will have a direct impact on the company’s future direction and potential for growth. By supporting Politan’s nominees, you may be helping to bring about positive changes that could enhance shareholder value and improve overall corporate governance.
How This Will Affect the World
As a leading player in the healthcare technology industry, Masimo Corporation’s actions and decisions have the potential to shape the future of patient care and medical innovation. By ensuring that the company is led by a strong and independent board of directors, shareholders can help promote transparency, accountability, and innovation in the broader healthcare sector.
Conclusion
Politan Capital Management’s open letter to Masimo Corporation shareholders highlights the importance of effective corporate governance and strategic leadership in driving long-term value creation. By supporting Politan’s nominees at the upcoming Annual Meeting, shareholders can help ensure that Masimo remains at the forefront of innovation in the healthcare technology industry.
